logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11672855 B1

PDFFull Text
Date of Patent:
Jun. 13, 2023

Filed:

Sep. 28, 2020

Mdck suspension cell lines in serum-free, chemically-defined media for vaccine production

Applicants:

National Health Research Institutes, Miaoli County, TW;

Fujifilm Irvine Scientific, Inc., Santa Ana, CA (US);

Inventors:

Jenny Bang, Santa Ana, CA (US);

Hsiao-Tzu Ni, Santa Ana, CA (US);

Alan Yung-Chih Hu, Zhunan Town, TW;

Tsai-Chuan Weng, Zhunan Town, TW;

Assignees:

NATIONAL HEALTH RESEARCH INSTITUTES, Miaoli County, TW;

FUJIFILM IRVINE SCIENTIFIC, INC., Santa Ana, CA (US);

Attorney:

Foley & Lardner LLP

Primary Examiner:

Catherine S Hibbert

Int. Cl.
CPC ...
C12N 5/00 (2006.01); A61K 39/145 (2006.01); A61K 39/12 (2006.01); C12N 5/071 (2010.01); C12N 7/00 (2006.01); C12N 15/85 (2006.01); A61P 31/16 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); A61K 39/12 (2013.01); C12N 5/0686 (2013.01); C12N 7/00 (2013.01); C12N 15/8509 (2013.01); A61P 31/16 (2018.01); C12N 2015/8518 (2013.01); C12N 2500/90 (2013.01); C12N 2500/99 (2013.01); C12N 2511/00 (2013.01); C12N 2513/00 (2013.01); C12N 2517/02 (2013.01); C12N 2760/16034 (2013.01); C12N 2760/16051 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16151 (2013.01); C12N 2760/16251 (2013.01);
Abstract

Disclosed is an adapted Madin-Darby canine kidney cell line capable of suspension culture in the absence of serum, and a chemically-defined medium for culture of the adapted MDCK cell line. Further disclosed are culture methods for growing the adapted MDCK cell line and methods for producing a vaccine from the adapted MDCK cell line grown in the chemically-defined medium.

Find Patent Forward Citations

Quick Actions:

Bang, Jenny. (2023). Mdck suspension cell lines in serum-free, chemically-defined media for vaccine production (U.S. Patent No. 11672855). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11672855

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…